{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:20:09Z","timestamp":1787570409686,"version":"build-2736575974"},"publisher-location":"Berlin, Heidelberg","reference-count":129,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/164_2026_835","type":"book-chapter","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:28:43Z","timestamp":1787567323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TAAR1 as a Target for Addiction Therapy"],"prefix":"10.1007","author":[{"given":"Samantha M.","family":"Rios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shkelzen","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"8016","key":"835_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J, Bodenstein SW, Evans DA, Hung CC, O\u2019Neill M, Reiman D, Tunyasuvunakool K, Wu Z, Zemgulyte A, Arvaniti E et al (2024) Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630(8016):493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w","journal-title":"Nature"},{"issue":"2","key":"835_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pbb.2011.10.025","volume":"101","author":"C Achat-Mendes","year":"2012","unstructured":"Achat-Mendes C, Lynch LJ, Sullivan KA, Vallender EJ, Miller GM (2012) Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1. Pharmacol Biochem Behav 101(2):201\u2013207. https:\/\/doi.org\/10.1016\/j.pbb.2011.10.025","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"835_CR3","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.62641\/aep.v53i5.1916","volume":"53","author":"Y Alnefeesi","year":"2025","unstructured":"Alnefeesi Y, Murtazina RZ, Gainetdinov RR (2025) Trace amine-associated receptors (TAARs): candidate targets in the treatment of bipolar disorders. Actas Esp Psiquiatr 53(5):1140\u20131153. https:\/\/doi.org\/10.62641\/aep.v53i5.1916","journal-title":"Actas Esp Psiquiatr"},{"issue":"2\u20133","key":"835_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/BF02244932","volume":"112","author":"JK Belknap","year":"1993","unstructured":"Belknap JK, Crabbe JC, Riggan J, O\u2019Toole LA (1993) Voluntary consumption of morphine in 15 inbred mouse strains. Psychopharmacology 112(2\u20133):352\u2013358. https:\/\/doi.org\/10.1007\/BF02244932","journal-title":"Psychopharmacology"},{"issue":"2","key":"835_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/s0091-3057(97)00421-8","volume":"59","author":"JK Belknap","year":"1998","unstructured":"Belknap JK, Riggan J, Cross S, Young ER, Gallaher EJ, Crabbe JC (1998) Genetic determinants of morphine activity and thermal responses in 15 inbred mouse strains. Pharmacol Biochem Behav 59(2):353\u2013360. https:\/\/doi.org\/10.1016\/s0091-3057(97)00421-8","journal-title":"Pharmacol Biochem Behav"},{"issue":"11\u201312","key":"835_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00335-013-9484-9","volume":"24","author":"JK Belknap","year":"2013","unstructured":"Belknap JK, McWeeney S, Reed C, Burkhart-Kasch S, McKinnon CS, Li N, Baba H, Scibelli AC, Hitzemann R, Phillips TJ (2013) Genetic factors involved in risk for methamphetamine intake and sensitization. Mamm Genome 24(11\u201312):446\u2013458. https:\/\/doi.org\/10.1007\/s00335-013-9484-9","journal-title":"Mamm Genome"},{"issue":"2","key":"835_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00041444-199422000-00003","volume":"4","author":"WH Berrettini","year":"1994","unstructured":"Berrettini WH, Alexander R, Ferraro TN, Vogel WH (1994) A study of oral morphine preference in inbred mouse strains. Psychiatr Genet 4(2):81\u201386. https:\/\/doi.org\/10.1097\/00041444-199422000-00003","journal-title":"Psychiatr Genet"},{"key":"835_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pharmthera.2017.07.002","volume":"180","author":"MD Berry","year":"2017","unstructured":"Berry MD, Gainetdinov RR, Hoener MC, Shahid M (2017) Pharmacology of human trace amine-associated receptors: therapeutic opportunities and challenges. Pharmacol Ther 180:161\u2013180. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.07.002","journal-title":"Pharmacol Ther"},{"issue":"16","key":"835_CR9","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1073\/pnas.151105198","volume":"98","author":"B Borowsky","year":"2001","unstructured":"Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98(16):8966\u20138971. https:\/\/doi.org\/10.1073\/pnas.151105198","journal-title":"Proc Natl Acad Sci USA"},{"issue":"47","key":"835_CR10","doi-asserted-by":"publisher","first-page":"20081","DOI":"10.1073\/pnas.0906522106","volume":"106","author":"A Bradaia","year":"2009","unstructured":"Bradaia A, Trube G, Stalder H, Norcross RD, Ozmen L, Wettstein JG, Pinard A, Buchy D, Gassmann M, Hoener MC, Bettler B (2009) The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci USA 106(47):20081\u201320086. https:\/\/doi.org\/10.1073\/pnas.0906522106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"835_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","volume":"60","author":"JR Bunzow","year":"2001","unstructured":"Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60(6):1181\u20131188. https:\/\/doi.org\/10.1124\/mol.60.6.1181","journal-title":"Mol Pharmacol"},{"issue":"5\u20136","key":"835_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pneurobio.2006.07.003","volume":"79","author":"SA Burchett","year":"2006","unstructured":"Burchett SA, Hicks TP (2006) The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol 79(5\u20136):223\u2013246. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.07.003","journal-title":"Prog Neurobiol"},{"issue":"3","key":"835_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/15598276251403469","volume":"20","author":"D Caples","year":"2025","unstructured":"Caples D, Srivastava S (2025) Pharmacotherapy for alcohol use disorder: A brief review of available options and their integration with lifestyle medicine approaches. Am J Lifestyle Med 20(3):15598276251403469. https:\/\/doi.org\/10.1177\/15598276251403469","journal-title":"Am J Lifestyle Med"},{"issue":"4","key":"835_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/cbdd.12018","volume":"81","author":"E Cichero","year":"2013","unstructured":"Cichero E, Espinoza S, Gainetdinov RR, Brasili L, Fossa P (2013) Insights into the structure and pharmacology of the human trace amine-associated receptor 1 (hTAAR1): homology modelling and docking studies. Chem Biol Drug Des 81(4):509\u2013516. https:\/\/doi.org\/10.1111\/cbdd.12018","journal-title":"Chem Biol Drug Des"},{"issue":"7","key":"835_CR15","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","volume":"104","author":"CC Cruickshank","year":"2009","unstructured":"Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104(7):1085\u20131099. https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02564.x","journal-title":"Addiction"},{"key":"835_CR16","doi-asserted-by":"publisher","unstructured":"Dash S, Shehensha S, Dhar AK (2026) Potential of small molecule TAAR-1 agonists for the therapy of neurodegenerative psychosis: A medicinal chemistry perspective. Mini Rev Med Chem. https:\/\/doi.org\/10.2174\/0113895575435251251114091416","DOI":"10.2174\/0113895575435251251114091416"},{"issue":"1","key":"835_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/2472555220945279","volume":"26","author":"AM Decker","year":"2021","unstructured":"Decker AM, Mathews KM, Blough BE, Gilmour BP (2021) Validation of a high-throughput calcium mobilization assay for the human trace amine-associated receptor 1. SLAS Discov 26(1):140\u2013150. https:\/\/doi.org\/10.1177\/2472555220945279","journal-title":"SLAS Discov"},{"issue":"7","key":"835_CR18","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1021\/acschemneuro.2c00086","volume":"13","author":"AM Decker","year":"2022","unstructured":"Decker AM, Brackeen MF, Mohammadkhani A, Kormos CM, Hesk D, Borgland SL, Blough BE (2022) Identification of a potent human trace amine-associated receptor 1 antagonist. ACS Chem Neurosci 13(7):1082\u20131095. https:\/\/doi.org\/10.1021\/acschemneuro.2c00086","journal-title":"ACS Chem Neurosci"},{"key":"835_CR19","doi-asserted-by":"publisher","unstructured":"Dedic N, Dworak H, Zeni C, Rutigliano G, Howes OD (2021) Therapeutic potential of TAAR1 agonists in schizophrenia: evidence from preclinical models and clinical studies. Int J Mol Sci 22(24). https:\/\/doi.org\/10.3390\/ijms222413185","DOI":"10.3390\/ijms222413185"},{"issue":"32","key":"835_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn1524","volume":"10","author":"A Diaz-Holguin","year":"2024","unstructured":"Diaz-Holguin A, Saarinen M, Vo DD, Sturchio A, Branzell N, Cabeza de Vaca I, Hu H, Mitjavila-Domenech N, Lindqvist A, Baranczewski P, Millan MJ, Yang Y, Carlsson J, Svenningsson P (2024) AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1. Sci Adv 10(32):eadn1524. https:\/\/doi.org\/10.1126\/sciadv.adn1524","journal-title":"Sci Adv"},{"key":"835_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neubiorev.2020.09.028","volume":"120","author":"S Dodd","year":"2021","unstructured":"Dodd S, Carvalho AF, Puri BK, Maes M, Bortolasci CC, Morris G, Berk M (2021) Trace Amine-Associated Receptor 1 (TAAR1): a new drug target for psychiatry? Neurosci Biobehav Rev 120:537\u2013541. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.09.028","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"835_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/adb.12003","volume":"19","author":"EC Eastwood","year":"2014","unstructured":"Eastwood EC, Phillips TJ (2014a) Opioid sensitivity in mice selectively bred to consume or not consume methamphetamine. Addict Biol 19(3):370\u2013379. https:\/\/doi.org\/10.1111\/adb.12003","journal-title":"Addict Biol"},{"issue":"2","key":"835_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/gbb.12100","volume":"13","author":"EC Eastwood","year":"2014","unstructured":"Eastwood EC, Phillips TJ (2014b) Morphine intake and the effects of naltrexone and buprenorphine on the acquisition of methamphetamine intake. Genes Brain Behav 13(2):226\u2013235. https:\/\/doi.org\/10.1111\/gbb.12100","journal-title":"Genes Brain Behav"},{"issue":"3\u20134","key":"835_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00335-017-9724-5","volume":"29","author":"EC Eastwood","year":"2018","unstructured":"Eastwood EC, Eshleman AJ, Janowsky A, Phillips TJ (2018) Verification of a genetic locus for methamphetamine intake and the impact of morphine. Mamm Genome 29(3\u20134):260\u2013272. https:\/\/doi.org\/10.1007\/s00335-017-9724-5","journal-title":"Mamm Genome"},{"issue":"9","key":"835_CR25","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1038\/npp.2015.65","volume":"40","author":"S Espinoza","year":"2015","unstructured":"Espinoza S, Lignani G, Caffino L, Maggi S, Sukhanov I, Leo D, Mus L, Emanuele M, Ronzitti G, Harmeier A, Medrihan L, Sotnikova TD, Chieregatti E, Hoener MC, Benfenati F, Tucci V, Fumagalli F, Gainetdinov RR (2015) TAAR1 modulates cortical glutamate NMDA receptor function. Neuropsychopharmacology 40(9):2217\u20132227. https:\/\/doi.org\/10.1038\/npp.2015.65","journal-title":"Neuropsychopharmacology"},{"key":"835_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","volume":"47","author":"AE Fleckenstein","year":"2007","unstructured":"Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681\u2013698. https:\/\/doi.org\/10.1146\/annurev.pharmtox.47.120505.105140","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"835_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuropharm.2008.07.002","volume":"56","author":"AE Fleckenstein","year":"2009","unstructured":"Fleckenstein AE, Volz TJ, Hanson GR (2009) Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropharmacology 56:133\u2013138. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.07.002","journal-title":"Neuropharmacology"},{"issue":"7","key":"835_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13285","volume":"28","author":"BA Frycz","year":"2023","unstructured":"Frycz BA, Nowicka K, Konopka A, Hoener MC, Bulska E, Kaczmarek L, Stefaniuk M (2023) Activation of trace amine-associated receptor 1 (TAAR1) transiently reduces alcohol drinking in socially housed mice. Addict Biol 28(7):e13285. https:\/\/doi.org\/10.1111\/adb.13285","journal-title":"Addict Biol"},{"issue":"3","key":"835_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.117.015305","volume":"70","author":"RR Gainetdinov","year":"2018","unstructured":"Gainetdinov RR, Hoener MC, Berry MD (2018) Trace amines and their receptors. Pharmacol Rev 70(3):549\u2013620. https:\/\/doi.org\/10.1124\/pr.117.015305","journal-title":"Pharmacol Rev"},{"issue":"1","key":"835_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s44277-025-00038-9","volume":"3","author":"RA Garcia-Reyes","year":"2025","unstructured":"Garcia-Reyes RA, Masso Quinones LN, Ruy H, Castro DC (2025) Neuropsychopharmacology in the era of artificial intelligence and biomolecule prediction software. NPP Digit Psychiatry Neurosci 3(1):16. https:\/\/doi.org\/10.1038\/s44277-025-00038-9","journal-title":"NPP Digit Psychiatry Neurosci"},{"issue":"12","key":"835_CR31","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1038\/s41380-022-01739-9","volume":"27","author":"D Grinchii","year":"2022","unstructured":"Grinchii D, Hoener MC, Khoury T, Dekhtiarenko R, Nejati Bervanlou R, Jezova D, Dremencov E (2022) Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats. Mol Psychiatry 27(12):4861\u20134868. https:\/\/doi.org\/10.1038\/s41380-022-01739-9","journal-title":"Mol Psychiatry"},{"key":"835_CR32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.bbr.2013.08.035","volume":"256","author":"NR Gubner","year":"2013","unstructured":"Gubner NR, Reed C, McKinnon CS, Phillips TJ (2013) Unique genetic factors influence sensitivity to the rewarding and aversive effects of methamphetamine versus cocaine. Behav Brain Res 256:420\u2013427. https:\/\/doi.org\/10.1016\/j.bbr.2013.08.035","journal-title":"Behav Brain Res"},{"issue":"4","key":"835_CR33","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1007\/s00259-025-07564-w","volume":"53","author":"A Haider","year":"2026","unstructured":"Haider A, Xiao Z, Chen J, Pfister SK, Zhou X, Li Y, Chaudhary A, Zhao C, Rong J, Paehler A, Mohr S, Norcross RD, Honer M, Mu L, Gobbi L, Schibli R, Hoener MC, Liang SH (2026) Preclinical development of [(18)F]TAAR1-2203 as a PET radioligand for imaging TAAR1 expression and receptor occupancy. Eur J Nucl Med Mol Imaging 53(4):2540\u20132553. https:\/\/doi.org\/10.1007\/s00259-025-07564-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"835_CR34","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/npp.2015.61","volume":"40","author":"JH Harkness","year":"2015","unstructured":"Harkness JH, Shi X, Janowsky A, Phillips TJ (2015) Trace amine-associated receptor 1 regulation of methamphetamine intake and related traits. Neuropsychopharmacology 40(9):2175\u20132184. https:\/\/doi.org\/10.1038\/npp.2015.61","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"835_CR35","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/jama.2025.26348","volume":"335","author":"MTH Harris","year":"2026","unstructured":"Harris MTH, Weinstein ZM, Walley AY (2026) Medications for opioid use disorder, opioid withdrawal, and opioid overdose: A review. JAMA 335(11):986\u2013998. https:\/\/doi.org\/10.1001\/jama.2025.26348","journal-title":"JAMA"},{"key":"835_CR36","doi-asserted-by":"publisher","unstructured":"Hitzemann R, Iancu OD, Reed C, Baba H, Lockwood DR, Phillips TJ (2019) Regional analysis of the brain transcriptome in mice bred for high and low methamphetamine consumption. Brain Sci 9(7). https:\/\/doi.org\/10.3390\/brainsci9070155","DOI":"10.3390\/brainsci9070155"},{"key":"835_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00260","volume":"10","author":"JJ Holst","year":"2019","unstructured":"Holst JJ (2019) From the Incretin concept and the discovery of GLP-1 to today\u2019s diabetes therapy. Front Endocrinol (Lausanne) 10:260. https:\/\/doi.org\/10.3389\/fendo.2019.00260","journal-title":"Front Endocrinol (Lausanne)"},{"key":"835_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110460","volume":"274","author":"C Houdant","year":"2025","unstructured":"Houdant C, Lamarche M, Fouquet G, Debuysscher V, Orzelska-Gorka J, Kruk-Slomka M, Biala G, Jeanblanc J, Naassila M (2025) Trace amine-associated receptor 1 agonists reduce alcohol drinking and differentially modulate dopamine release in the nucleus accumbens of alcohol preferring mice. Neuropharmacology 274:110460. https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110460","journal-title":"Neuropharmacology"},{"key":"835_CR39","doi-asserted-by":"publisher","unstructured":"Howes OD, Vano LJ, Petty AE, Rutigliano G, Halff EF, Veronese M, Kaar SJ, Nordio G, Lopes EF, Cragg SJ, Natesan S, Withers DJ, Rabiner EA, Wells L, Dedic N, Milanovic S, Koblan K, Hopkins SC, McCutcheon RA (2025) TAAR1 regulates presynaptic dopamine function: evidence from preclinical studies and a phase 1b trial in patients with schizophrenia. Biol Psychiatry. https:\/\/doi.org\/10.1016\/j.biopsych.2025.10.013","DOI":"10.1016\/j.biopsych.2025.10.013"},{"issue":"9","key":"835_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.molpha.2025.100064","volume":"107","author":"JK Huey","year":"2025","unstructured":"Huey JK, Shi X, Schutzer WE, Janowsky A, Abbas AI (2025) Trace amine-associated receptor 1 agonists differentially regulate dopamine transporter function. Mol Pharmacol 107(9):100064. https:\/\/doi.org\/10.1016\/j.molpha.2025.100064","journal-title":"Mol Pharmacol"},{"key":"835_CR41","doi-asserted-by":"publisher","unstructured":"Huhulea EN, Frishman WH, Aronow WS (2026) Emerging and established pharmacotherapies for smoking cessation: a review. Cardiol Rev. https:\/\/doi.org\/10.1097\/CRD.0000000000001171","DOI":"10.1097\/CRD.0000000000001171"},{"key":"835_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2026.178861","volume":"1023","author":"M Jahangir","year":"2026","unstructured":"Jahangir M, Gowtham L, Nath M, Halder N, Velpandian T (2026) Trace amine associated receptors in neuronal circuits: mechanistic insights for therapeutic interventions. Eur J Pharmacol 1023:178861. https:\/\/doi.org\/10.1016\/j.ejphar.2026.178861","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"835_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00228-025-03809-7","volume":"81","author":"A Jarab","year":"2025","unstructured":"Jarab A, Al-Qerem W, Khdour A, Awadallah H, Mimi Y, Khdour M (2025) Novel pharmaceutical treatment approaches for schizophrenia: a systematic literature review. Eur J Clin Pharmacol 81(4):525\u2013541. https:\/\/doi.org\/10.1007\/s00228-025-03809-7","journal-title":"Eur J Clin Pharmacol"},{"key":"835_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1670883","volume":"19","author":"J Jiang","year":"2025","unstructured":"Jiang J, Li X, Hu AF, Zhou GJ, Gao YH, Xu C, Wu XM, Wang HJ (2025) Nicotine and neuronal nicotinic acetylcholine receptors: unraveling the mechanisms of nicotine addiction. Front Neurosci 19:1670883. https:\/\/doi.org\/10.3389\/fnins.2025.1670883","journal-title":"Front Neurosci"},{"key":"835_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ejphar.2015.06.019","volume":"761","author":"L Jing","year":"2015","unstructured":"Jing L, Li JX (2015) Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction. Eur J Pharmacol 761:345\u2013352. https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.019","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"835_CR46","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1073\/pnas.0407737102","volume":"102","author":"KM Kahlig","year":"2005","unstructured":"Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci USA 102(9):3495\u20133500. https:\/\/doi.org\/10.1073\/pnas.0407737102","journal-title":"Proc Natl Acad Sci USA"},{"key":"835_CR47","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.biopha.2016.07.002","volume":"83","author":"MZ Khan","year":"2016","unstructured":"Khan MZ, Nawaz W (2016) The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system. Biomed Pharmacother 83:439\u2013449. https:\/\/doi.org\/10.1016\/j.biopha.2016.07.002","journal-title":"Biomed Pharmacother"},{"key":"835_CR48","doi-asserted-by":"publisher","unstructured":"Kuvarzin SR, Sukhanov I, Onokhin K, Zakharov K, Gainetdinov RR (2023) Unlocking the therapeutic potential of Ulotaront as a trace amine-associated receptor 1 agonist for neuropsychiatric disorders. Biomedicine 11(7). https:\/\/doi.org\/10.3390\/biomedicines11071977","DOI":"10.3390\/biomedicines11071977"},{"issue":"Pt B","key":"835_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejphar.2015.06.026","volume":"763","author":"VM Lam","year":"2015","unstructured":"Lam VM, Espinoza S, Gerasimov AS, Gainetdinov RR, Salahpour A (2015) In-vivo pharmacology of trace-amine associated receptor 1. Eur J Pharmacol 763(Pt B):136\u2013142. https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.026","journal-title":"Eur J Pharmacol"},{"key":"835_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00953","volume":"9","author":"VM Lam","year":"2018","unstructured":"Lam VM, Mielnik CA, Baimel C, Beerepoot P, Espinoza S, Sukhanov I, Horsfall W, Gainetdinov RR, Borgland SL, Ramsey AJ, Salahpour A (2018) Behavioral effects of a potential novel TAAR1 antagonist. Front Pharmacol 9:953. https:\/\/doi.org\/10.3389\/fphar.2018.00953","journal-title":"Front Pharmacol"},{"key":"835_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1598048","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Wan L, Dong J, Li J, Liu J (2025) Trace amine-associated receptors as potential targets for the treatment of anxiety and depression. Front Pharmacol 16:1598048. https:\/\/doi.org\/10.3389\/fphar.2025.1598048","journal-title":"Front Pharmacol"},{"issue":"20","key":"835_CR52","doi-asserted-by":"publisher","first-page":"18593","DOI":"10.1021\/acs.jmedchem.4c01961","volume":"67","author":"Y Lin","year":"2024","unstructured":"Lin Y, Wang J, Shi F, Yang L, Wu S, Qiao A, Ye S (2024) Molecular mechanisms of methamphetamine-induced addiction via TAAR1 activation. J Med Chem 67(20):18593\u201318605. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01961","journal-title":"J Med Chem"},{"issue":"3","key":"835_CR53","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/jpet.107.132647","volume":"324","author":"L Lindemann","year":"2008","unstructured":"Lindemann L, Meyer CA, Jeanneau K, Bradaia A, Ozmen L, Bluethmann H, Bettler B, Wettstein JG, Borroni E, Moreau JL, Hoener MC (2008) Trace amine-associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther 324(3):948\u2013956. https:\/\/doi.org\/10.1124\/jpet.107.132647","journal-title":"J Pharmacol Exp Ther"},{"key":"835_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fphar.2018.00279","volume":"9","author":"JF Liu","year":"2018","unstructured":"Liu JF, Li JX (2018) TAAR1 in addiction: looking beyond the tip of the iceberg. Front Pharmacol 9:279. https:\/\/doi.org\/10.3389\/fphar.2018.00279","journal-title":"Front Pharmacol"},{"issue":"4","key":"835_CR55","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1523\/JNEUROSCI.2006-16.2016","volume":"37","author":"JF Liu","year":"2017","unstructured":"Liu JF, Siemian JN, Seaman R Jr, Zhang Y, Li JX (2017) Role of TAAR1 within the subregions of the mesocorticolimbic dopaminergic system in cocaine-seeking behavior. J Neurosci 37(4):882\u2013892. https:\/\/doi.org\/10.1523\/JNEUROSCI.2006-16.2016","journal-title":"J Neurosci"},{"issue":"15","key":"835_CR56","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1111\/bph.15061","volume":"177","author":"J Liu","year":"2020","unstructured":"Liu J, Johnson B, Wu R, Seaman R Jr, Vu J, Zhu Q, Zhang Y, Li JX (2020a) TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking. Br J Pharmacol 177(15):3403\u20133414. https:\/\/doi.org\/10.1111\/bph.15061","journal-title":"Br J Pharmacol"},{"issue":"2","key":"835_CR57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10571-020-00792-8","volume":"40","author":"J Liu","year":"2020","unstructured":"Liu J, Wu R, Li JX (2020b) TAAR1 and psychostimulant addiction. Cell Mol Neurobiol 40(2):229\u2013238. https:\/\/doi.org\/10.1007\/s10571-020-00792-8","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"835_CR58","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/bph.15335","volume":"178","author":"J Liu","year":"2021","unstructured":"Liu J, Seaman R Jr, Johnson B, Wu R, Vu J, Tian J, Zhang Y, Li JX (2021) Activation of trace amine-associated receptor 1 selectively attenuates the reinforcing effects of morphine. Br J Pharmacol 178(4):933\u2013945. https:\/\/doi.org\/10.1111\/bph.15335","journal-title":"Br J Pharmacol"},{"issue":"10","key":"835_CR59","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1007\/s00213-022-06222-5","volume":"239","author":"J Liu","year":"2022","unstructured":"Liu J, Wu R, Johnson B, Zhang Y, Zhu Q, Li JX (2022a) Selective TAAR1 agonists induce conditioned taste aversion. Psychopharmacology 239(10):3345\u20133353. https:\/\/doi.org\/10.1007\/s00213-022-06222-5","journal-title":"Psychopharmacology"},{"issue":"4","key":"835_CR60","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1038\/s41380-022-01448-3","volume":"27","author":"J Liu","year":"2022","unstructured":"Liu J, Wu R, Seaman R Jr, Manz KM, Johnson B, Vu J, Huang Y, Zhang Y, Robison AJ, Neve R, Grueter BA, Dietz D, Li JX (2022b) TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKIIalpha activity in the NAc. Mol Psychiatry 27(4):2136\u20132145. https:\/\/doi.org\/10.1038\/s41380-022-01448-3","journal-title":"Mol Psychiatry"},{"issue":"7992","key":"835_CR61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-023-06775-1","volume":"624","author":"H Liu","year":"2023","unstructured":"Liu H, Zheng Y, Wang Y, Wang Y, He X, Xu P, Huang S, Yuan Q, Zhang X, Wang L, Jiang K, Chen H, Li Z, Liu W, Wang S, Xu HE, Xu F (2023) Recognition of methamphetamine and other amines by trace amine receptor TAAR1. Nature 624(7992):663\u2013671. https:\/\/doi.org\/10.1038\/s41586-023-06775-1","journal-title":"Nature"},{"key":"835_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108580","volume":"253","author":"J Liu","year":"2024","unstructured":"Liu J, Wu R, Li JX (2024) TAAR1 as an emerging target for the treatment of psychiatric disorders. Pharmacol Ther 253:108580. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108580","journal-title":"Pharmacol Ther"},{"key":"835_CR63","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.neuroscience.2025.08.025","volume":"584","author":"DN Liu","year":"2025","unstructured":"Liu DN, Sun M, Zhang XQ, Li JT, Si TM, Su YA (2025) A quantitative analysis of TAAR1-positive cells in whole mouse brain by FDISCO technology. Neuroscience 584:286\u2013294. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.08.025","journal-title":"Neuroscience"},{"issue":"10","key":"835_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220270","volume":"14","author":"JM Loftis","year":"2019","unstructured":"Loftis JM, Lasarev M, Shi X, Lapidus J, Janowsky A, Hoffman WF, Huckans M (2019) Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence. PLoS One 14(10):e0220270. https:\/\/doi.org\/10.1371\/journal.pone.0220270","journal-title":"PLoS One"},{"key":"835_CR65","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/bs.pbr.2025.01.012","volume":"291","author":"SR Mehr","year":"2025","unstructured":"Mehr SR, Nakhaei B, Soleimani H, Madadlou SK, Abbasi Maleky A, Abbasi-Maleki S (2025) Addiction and stress: exploring the reward pathways in brain affected by different drugs. Prog Brain Res 291:381\u2013404. https:\/\/doi.org\/10.1016\/bs.pbr.2025.01.012","journal-title":"Prog Brain Res"},{"issue":"2","key":"835_CR66","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1471-4159.2010.07109.x","volume":"116","author":"GM Miller","year":"2011","unstructured":"Miller GM (2011) The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J Neurochem 116(2):164\u2013176. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07109.x","journal-title":"J Neurochem"},{"key":"835_CR67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuro.2017.09.006","volume":"63","author":"NB Miner","year":"2017","unstructured":"Miner NB, Elmore JS, Baumann MH, Phillips TJ, Janowsky A (2017) Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity. Neurotoxicology 63:57\u201369. https:\/\/doi.org\/10.1016\/j.neuro.2017.09.006","journal-title":"Neurotoxicology"},{"key":"835_CR68","doi-asserted-by":"publisher","unstructured":"Moiseenko VI, Apryatina VA, Gainetdinov RR, Apryatin SA (2024) Trace amine-associated receptors\u2019 role in immune system functions. Biomedicine 12(4). https:\/\/doi.org\/10.3390\/biomedicines12040893","DOI":"10.3390\/biomedicines12040893"},{"issue":"5","key":"835_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12640","volume":"19","author":"JRK Mootz","year":"2020","unstructured":"Mootz JRK, Miner NB, Phillips TJ (2020) Differential genetic risk for methamphetamine intake confers differential sensitivity to the temperature-altering effects of other addictive drugs. Genes Brain Behav 19(5):e12640. https:\/\/doi.org\/10.1111\/gbb.12640","journal-title":"Genes Brain Behav"},{"key":"835_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00807","volume":"8","author":"J Muhlhaus","year":"2017","unstructured":"Muhlhaus J, Dinter J, Jyrch S, Teumer A, Jacobi SF, Homuth G, Kuhnen P, Wiegand S, Gruters A, Volzke H, Raile K, Kleinau G, Krude H, Biebermann H (2017) Investigation of naturally occurring single-nucleotide variants in human TAAR1. Front Pharmacol 8:807. https:\/\/doi.org\/10.3389\/fphar.2017.00807","journal-title":"Front Pharmacol"},{"issue":"1","key":"835_CR71","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0091-3057(87)90481-3","volume":"27","author":"T Muraki","year":"1987","unstructured":"Muraki T, Kato R (1987) Genetic analysis of hypothermia induced by morphine in two strains of inbred mice. Pharmacol Biochem Behav 27(1):87\u201391. https:\/\/doi.org\/10.1016\/0091-3057(87)90481-3","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"835_CR72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","volume":"129","author":"WJ Panenka","year":"2013","unstructured":"Panenka WJ, Procyshyn RM, Lecomte T, MacEwan GW, Flynn SW, Honer WG, Barr AM (2013) Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend 129(3):167\u2013179. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.11.016","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"835_CR73","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1038\/npp.2014.88","volume":"39","author":"Y Pei","year":"2014","unstructured":"Pei Y, Lee J, Leo D, Gainetdinov RR, Hoener MC, Canales JJ (2014) Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking. Neuropsychopharmacology 39(10):2299\u20132308. https:\/\/doi.org\/10.1038\/npp.2014.88","journal-title":"Neuropsychopharmacology"},{"key":"835_CR74","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pnpbp.2015.05.014","volume":"63","author":"Y Pei","year":"2015","unstructured":"Pei Y, Mortas P, Hoener MC, Canales JJ (2015) Selective activation of the trace amine-associated receptor 1 decreases cocaine\u2019s reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds. Prog Neuro-Psychopharmacol Biol Psychiatry 63:70\u201375. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.05.014","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"835_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00148","volume":"10","author":"Y Pei","year":"2016","unstructured":"Pei Y, Asif-Malik A, Canales JJ (2016) Trace amines and the trace amine-associated receptor 1: pharmacology, neurochemistry, and clinical implications. Front Neurosci 10:148. https:\/\/doi.org\/10.3389\/fnins.2016.00148","journal-title":"Front Neurosci"},{"issue":"5","key":"835_CR76","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/adb.12410","volume":"22","author":"Y Pei","year":"2017","unstructured":"Pei Y, Asif-Malik A, Hoener M, Canales JJ (2017) A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment. Addict Biol 22(5):1246\u20131256. https:\/\/doi.org\/10.1111\/adb.12410","journal-title":"Addict Biol"},{"issue":"10","key":"835_CR77","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1016\/S0021-9258(17)37272-1","volume":"269","author":"D Peter","year":"1994","unstructured":"Peter D, Jimenez J, Liu Y, Kim J, Edwards RH (1994) The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem 269(10):7231\u20137237. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8125935","journal-title":"J Biol Chem"},{"key":"835_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00327","volume":"9","author":"TJ Phillips","year":"2015","unstructured":"Phillips TJ, Shabani S (2015) An animal model of differential genetic risk for methamphetamine intake. Front Neurosci 9:327. https:\/\/doi.org\/10.3389\/fnins.2015.00327","journal-title":"Front Neurosci"},{"key":"835_CR79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/bs.irn.2016.02.001","volume":"126","author":"TJ Phillips","year":"2016","unstructured":"Phillips TJ, Mootz JR, Reed C (2016) Identification of treatment targets in a genetic mouse model of voluntary methamphetamine drinking. Int Rev Neurobiol 126:39\u201385. https:\/\/doi.org\/10.1016\/bs.irn.2016.02.001","journal-title":"Int Rev Neurobiol"},{"key":"835_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.725839","volume":"12","author":"TJ Phillips","year":"2021","unstructured":"Phillips TJ, Roy T, Aldrich SJ, Baba H, Erk J, Mootz JRK, Reed C, Chesler EJ (2021) Confirmation of a causal Taar1 allelic variant in addiction-relevant methamphetamine behaviors. Front Psych 12:725839. https:\/\/doi.org\/10.3389\/fpsyt.2021.725839","journal-title":"Front Psych"},{"issue":"1","key":"835_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01232-3","volume":"31","author":"L Pretorius","year":"2025","unstructured":"Pretorius L, Coetzee JA, Santos APD, Smith C (2025) Modulating autism spectrum disorder pathophysiology using a trace amine-focused approach: targeting the gut. Mol Med 31(1):198. https:\/\/doi.org\/10.1186\/s10020-025-01232-3","journal-title":"Mol Med"},{"key":"835_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00993","volume":"8","author":"C Reed","year":"2018","unstructured":"Reed C, Baba H, Zhu Z, Erk J, Mootz JR, Varra NM, Williams RW, Phillips TJ (2018) A spontaneous mutation in Taar1 impacts methamphetamine-related traits exclusively in DBA\/2 mice from a single vendor. Front Pharmacol 8:993. https:\/\/doi.org\/10.3389\/fphar.2017.00993","journal-title":"Front Pharmacol"},{"issue":"20","key":"835_CR83","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1073\/pnas.1103029108","volume":"108","author":"FG Revel","year":"2011","unstructured":"Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, Bettler B, Caron MG, Wettstein JG, Hoener MC (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci USA 108(20):8485\u20138490. https:\/\/doi.org\/10.1073\/pnas.1103029108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"835_CR84","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1038\/npp.2012.109","volume":"37","author":"FG Revel","year":"2012","unstructured":"Revel FG, Meyer CA, Bradaia A, Jeanneau K, Calcagno E, Andre CB, Haenggi M, Miss MT, Galley G, Norcross RD, Invernizzi RW, Wettstein JG, Moreau JL, Hoener MC (2012a) Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Neuropsychopharmacology 37(12):2580\u20132592. https:\/\/doi.org\/10.1038\/npp.2012.109","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"835_CR85","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","volume":"72","author":"FG Revel","year":"2012","unstructured":"Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Velazquez-Sanchez C, Sotnikova TD, Morairty SR, Harmeier A, Groebke Zbinden K, Norcross RD, Bradaia A, Kilduff TS, Biemans B, Pouzet B, Caron MG, Canales JJ, Wallace TL, Wettstein JG, Hoener MC (2012b) Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry 72(11):934\u2013942. https:\/\/doi.org\/10.1016\/j.biopsych.2012.05.014","journal-title":"Biol Psychiatry"},{"key":"835_CR86","doi-asserted-by":"publisher","unstructured":"Rios SM, Mootz JRK, Phillips TJ, Ingram SL (2025) Absence of TAAR1 function increases methamphetamine-induced excitability of dorsal raphe serotonin neurons and drives binge-level methamphetamine intake. Neuropsychopharmacology. https:\/\/doi.org\/10.1038\/s41386-025-02063-w","DOI":"10.1038\/s41386-025-02063-w"},{"key":"835_CR87","doi-asserted-by":"publisher","unstructured":"Robinson TE, Berridge KC (2026) Can the incentive-sensitization theory of addiction incorporate addiction to opioid drugs? Psychopharmacology. https:\/\/doi.org\/10.1007\/s00213-025-07001-8","DOI":"10.1007\/s00213-025-07001-8"},{"issue":"1\u20133","key":"835_CR88","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","volume":"479","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479(1\u20133):23\u201340. https:\/\/doi.org\/10.1016\/j.ejphar.2003.08.054","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"835_CR89","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39(1):32\u201341. https:\/\/doi.org\/10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","journal-title":"Synapse"},{"issue":"2","key":"835_CR90","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10571-019-00743-y","volume":"40","author":"G Rutigliano","year":"2020","unstructured":"Rutigliano G, Zucchi R (2020) Molecular variants in human trace amine-associated receptors and their implications in mental and metabolic disorders. Cell Mol Neurobiol 40(2):239\u2013255. https:\/\/doi.org\/10.1007\/s10571-019-00743-y","journal-title":"Cell Mol Neurobiol"},{"key":"835_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00987","volume":"8","author":"G Rutigliano","year":"2018","unstructured":"Rutigliano G, Accorroni A, Zucchi R (2018) The case for TAAR1 as a modulator of central nervous system function. Front Pharmacol 8:987. https:\/\/doi.org\/10.3389\/fphar.2017.00987","journal-title":"Front Pharmacol"},{"issue":"6","key":"835_CR92","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/14728222.2018.1480723","volume":"22","author":"MD Schwartz","year":"2018","unstructured":"Schwartz MD, Canales JJ, Zucchi R, Espinoza S, Sukhanov I, Gainetdinov RR (2018) Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opin Ther Targets 22(6):513\u2013526. https:\/\/doi.org\/10.1080\/14728222.2018.1480723","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"835_CR93","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1601-183X.2011.00700.x","volume":"10","author":"S Shabani","year":"2011","unstructured":"Shabani S, McKinnon CS, Reed C, Cunningham CL, Phillips TJ (2011) Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intake. Genes Brain Behav 10(6):625\u2013636. https:\/\/doi.org\/10.1111\/j.1601-183X.2011.00700.x","journal-title":"Genes Brain Behav"},{"issue":"7","key":"835_CR94","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.neuropharm.2012.01.002","volume":"62","author":"S Shabani","year":"2012","unstructured":"Shabani S, Dobbs LK, Ford MM, Mark GP, Finn DA, Phillips TJ (2012a) A genetic animal model of differential sensitivity to methamphetamine reinforcement. Neuropharmacology 62(7):2169\u20132177. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.01.002","journal-title":"Neuropharmacology"},{"issue":"2","key":"835_CR95","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.neuropharm.2011.11.005","volume":"62","author":"S Shabani","year":"2012","unstructured":"Shabani S, McKinnon CS, Cunningham CL, Phillips TJ (2012b) Profound reduction in sensitivity to the aversive effects of methamphetamine in mice bred for high methamphetamine intake. Neuropharmacology 62(2):1134\u20131141. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.11.005","journal-title":"Neuropharmacology"},{"key":"835_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00493","volume":"10","author":"S Shabani","year":"2016","unstructured":"Shabani S, Houlton SK, Hellmuth L, Mojica E, Mootz JR, Zhu Z, Reed C, Phillips TJ (2016) A mouse model for binge-level methamphetamine use. Front Neurosci 10:493. https:\/\/doi.org\/10.3389\/fnins.2016.00493","journal-title":"Front Neurosci"},{"issue":"10","key":"835_CR97","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41386-023-01578-4","volume":"48","author":"S Shabani","year":"2023","unstructured":"Shabani S, Houlton S, Ghimire B, Tonello D, Reed C, Baba H, Aldrich S, Phillips TJ (2023) Robust aversive effects of trace amine-associated receptor 1 activation in mice. Neuropsychopharmacology 48(10):1446\u20131454. https:\/\/doi.org\/10.1038\/s41386-023-01578-4","journal-title":"Neuropsychopharmacology"},{"key":"835_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1464550","volume":"15","author":"B Shajan","year":"2024","unstructured":"Shajan B, Bastiampillai T, Hellyer SD, Nair PC (2024a) Unlocking the secrets of trace amine-associated receptor 1 agonists: new horizon in neuropsychiatric treatment. Front Psych 15:1464550. https:\/\/doi.org\/10.3389\/fpsyt.2024.1464550","journal-title":"Front Psych"},{"issue":"1","key":"835_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-024-00620-w","volume":"18","author":"B Shajan","year":"2024","unstructured":"Shajan B, Marri S, Bastiampillai T, Gregory KJ, Hellyer SD, Nair PC (2024b) Trace amine associated receptor 1: predicted effects of single nucleotide variants on structure-function in geographically diverse populations. Hum Genomics 18(1):61. https:\/\/doi.org\/10.1186\/s40246-024-00620-w","journal-title":"Hum Genomics"},{"issue":"24","key":"835_CR100","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1016\/j.cell.2023.10.014","volume":"186","author":"P Shang","year":"2023","unstructured":"Shang P, Rong N, Jiang JJ, Cheng J, Zhang MH, Kang D, Qi L, Guo L, Yang GM, Liu Q, Zhou Z, Li XB, Zhu KK, Meng QB, Han X, Yan W, Kong Y, Yang L, Wang X et al (2023) Structural and signaling mechanisms of TAAR1 enabled preferential agonist design. Cell 186(24):5347\u20135362 e5324. https:\/\/doi.org\/10.1016\/j.cell.2023.10.014","journal-title":"Cell"},{"key":"835_CR101","doi-asserted-by":"publisher","unstructured":"Shemiakova TS, Efimova EV, Gainetdinov RR (2024) TAARs as novel therapeutic targets for the treatment of depression: A narrative review of the interconnection with monoamines and adult neurogenesis. Biomedicine 12(6). https:\/\/doi.org\/10.3390\/biomedicines12061263","DOI":"10.3390\/biomedicines12061263"},{"issue":"3","key":"835_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152581","volume":"11","author":"X Shi","year":"2016","unstructured":"Shi X, Walter NA, Harkness JH, Neve KA, Williams RW, Lu L, Belknap JK, Eshleman AJ, Phillips TJ, Janowsky A (2016) Genetic polymorphisms affect mouse and human trace amine-associated receptor 1 function. PLoS One 11(3):e0152581. https:\/\/doi.org\/10.1371\/journal.pone.0152581","journal-title":"PLoS One"},{"key":"835_CR103","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.21302.1","volume":"9","author":"S Siafis","year":"2024","unstructured":"Siafis S, Chiocchia V, Macleod MR, Austin C, Homiar A, Tinsdeall F, Friedrich C, Ramage FJ, Kennett J, Nomura N, Maksym O, Rutigliano G, Vano LJ, McCutcheon RA, Gilbert D, Ostinelli EG, Stansfield C, Dehdarirad H, Juma DO et al (2024) Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data. Wellcome Open Res 9:182. https:\/\/doi.org\/10.12688\/wellcomeopenres.21302.1","journal-title":"Wellcome Open Res"},{"issue":"3","key":"835_CR104","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1046\/j.1471-4159.1998.71031289.x","volume":"71","author":"HH Sitte","year":"1998","unstructured":"Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71(3):1289\u20131297. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.71031289.x","journal-title":"J Neurochem"},{"issue":"2","key":"835_CR105","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1124\/mol.109.055970","volume":"76","author":"TD Sotnikova","year":"2009","unstructured":"Sotnikova TD, Caron MG, Gainetdinov RR (2009) Trace amine-associated receptors as emerging therapeutic targets. Mol Pharmacol 76(2):229\u2013235. https:\/\/doi.org\/10.1124\/mol.109.055970","journal-title":"Mol Pharmacol"},{"key":"835_CR106","doi-asserted-by":"publisher","unstructured":"Stafford AM, Reed C, Baba H, Walter NA, Mootz JR, Williams RW, Neve KA, Fedorov LM, Janowsky AJ, Phillips TJ (2019) Taar1 gene variants have a causal role in methamphetamine intake and response and interact with Oprm1. elife 8. https:\/\/doi.org\/10.7554\/eLife.46472","DOI":"10.7554\/eLife.46472"},{"issue":"4","key":"835_CR107","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bmcl.2010.12.075","volume":"21","author":"H Stalder","year":"2011","unstructured":"Stalder H, Hoener MC, Norcross RD (2011) Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773). Bioorg Med Chem Lett 21(4):1227\u20131231. https:\/\/doi.org\/10.1016\/j.bmcl.2010.12.075","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"835_CR108","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","volume":"75","author":"D Sulzer","year":"2005","unstructured":"Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75(6):406\u2013433. https:\/\/doi.org\/10.1016\/j.pneurobio.2005.04.003","journal-title":"Prog Neurobiol"},{"key":"835_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetlet.2021.153007","volume":"70","author":"J Sun","year":"2021","unstructured":"Sun J, Chen J, Kumata K, Xiao Z, Rong J, Haider A, Shao T, Wang L, Xu H, Zhang M-R, Liang SH (2021) Imaging the trace amine-associated receptor 1 by positron emission tomography. Tetrahedron Lett 70:153007. https:\/\/doi.org\/10.1016\/j.tetlet.2021.153007","journal-title":"Tetrahedron Lett"},{"issue":"4","key":"835_CR110","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.chembiol.2008.03.004","volume":"15","author":"ES Tan","year":"2008","unstructured":"Tan ES, Groban ES, Jacobson MP, Scanlan TS (2008) Toward deciphering the code to aminergic G protein-coupled receptor drug design. Chem Biol 15(4):343\u2013353. https:\/\/doi.org\/10.1016\/j.chembiol.2008.03.004","journal-title":"Chem Biol"},{"issue":"10","key":"835_CR111","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/npp.2014.91","volume":"39","author":"DA Thorn","year":"2014","unstructured":"Thorn DA, Jing L, Qiu Y, Gancarz-Kausch AM, Galuska CM, Dietz DM, Zhang Y, Li JX (2014) Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats. Neuropsychopharmacology 39(10):2309\u20132316. https:\/\/doi.org\/10.1038\/npp.2014.91","journal-title":"Neuropsychopharmacology"},{"key":"835_CR112","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neuroscience.2013.11.059","volume":"259","author":"B Torres","year":"2014","unstructured":"Torres B, Ruoho AE (2014) N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux. Neuroscience 259:194\u2013202. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.11.059","journal-title":"Neuroscience"},{"issue":"S1","key":"835_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.05856","volume":"34","author":"S Underhill","year":"2020","unstructured":"Underhill S, Amara S (2020) MDMA and TAAR1-mediated RhoA activation in serotonin neurons. FASEB J 34(S1):1\u20131. https:\/\/doi.org\/10.1096\/fasebj.2020.34.s1.05856","journal-title":"FASEB J"},{"issue":"2","key":"835_CR114","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neuron.2014.05.043","volume":"83","author":"SM Underhill","year":"2014","unstructured":"Underhill SM, Wheeler DS, Li M, Watts SD, Ingram SL, Amara SG (2014) Amphetamine modulates excitatory neurotransmission through endocytosis of the glutamate transporter EAAT3 in dopamine neurons. Neuron 83(2):404\u2013416. https:\/\/doi.org\/10.1016\/j.neuron.2014.05.043","journal-title":"Neuron"},{"issue":"6","key":"835_CR115","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s11064-019-02939-6","volume":"45","author":"SM Underhill","year":"2020","unstructured":"Underhill SM, Colt MS, Amara SG (2020) Amphetamine stimulates endocytosis of the norepinephrine and neuronal glutamate transporters in cultured locus Coeruleus neurons. Neurochem Res 45(6):1410\u20131419. https:\/\/doi.org\/10.1007\/s11064-019-02939-6","journal-title":"Neurochem Res"},{"issue":"4","key":"835_CR116","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41380-019-0469-2","volume":"26","author":"SM Underhill","year":"2021","unstructured":"Underhill SM, Hullihen PD, Chen J, Fenollar-Ferrer C, Rizzo MA, Ingram SL, Amara SG (2021) Amphetamines signal through intracellular TAAR1 receptors coupled to Galpha(13) and Galpha(S) in discrete subcellular domains. Mol Psychiatry 26(4):1208\u20131223. https:\/\/doi.org\/10.1038\/s41380-019-0469-2","journal-title":"Mol Psychiatry"},{"issue":"4","key":"835_CR117","doi-asserted-by":"publisher","first-page":"980","DOI":"10.22088\/IJMCM.BUMS.14.4.980","volume":"14","author":"M Voevoda","year":"2025","unstructured":"Voevoda M, Filimonov D, Knyazev R, Ishchenko R, Eresko A, Trubnikova N, Belotserkovskaya M, Kisilenko I, Nosova I, Solopov M (2025) Trace amine-associated receptor 1: role in the implementation of neuroprotective signaling pathways. Int J Mol Cell Med 14(4):980\u2013993. https:\/\/doi.org\/10.22088\/IJMCM.BUMS.14.4.980","journal-title":"Int J Mol Cell Med"},{"issue":"8","key":"835_CR118","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1601-183X.2009.00522.x","volume":"8","author":"JM Wheeler","year":"2009","unstructured":"Wheeler JM, Reed C, Burkhart-Kasch S, Li N, Cunningham CL, Janowsky A, Franken FH, Wiren KM, Hashimoto JG, Scibelli AC, Phillips TJ (2009) Genetically correlated effects of selective breeding for high and low methamphetamine consumption. Genes Brain Behav 8(8):758\u2013771. https:\/\/doi.org\/10.1111\/j.1601-183X.2009.00522.x","journal-title":"Genes Brain Behav"},{"issue":"51","key":"835_CR119","doi-asserted-by":"publisher","first-page":"E7138","DOI":"10.1073\/pnas.1511670112","volume":"112","author":"DS Wheeler","year":"2015","unstructured":"Wheeler DS, Underhill SM, Stolz DB, Murdoch GH, Thiels E, Romero G, Amara SG (2015) Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine. Proc Natl Acad Sci USA 112(51):E7138\u2013E7147. https:\/\/doi.org\/10.1073\/pnas.1511670112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"835_CR120","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1601-183X.2006.00292.x","volume":"6","author":"TD Wolinsky","year":"2007","unstructured":"Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P, Branchek T, Gerald CP (2007) The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6(7):628\u2013639. https:\/\/doi.org\/10.1111\/j.1601-183X.2006.00292.x","journal-title":"Genes Brain Behav"},{"issue":"12","key":"835_CR121","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s40263-021-00871-4","volume":"35","author":"R Wu","year":"2021","unstructured":"Wu R, Li JX (2021) Potential of ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the management of substance use Disorders. CNS Drugs 35(12):1239\u20131248. https:\/\/doi.org\/10.1007\/s40263-021-00871-4","journal-title":"CNS Drugs"},{"issue":"1","key":"835_CR122","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13075","volume":"27","author":"R Wu","year":"2022","unstructured":"Wu R, Liu J, Johnson B, Huang Y, Zhang Y, Li JX (2022) Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects. Addict Biol 27(1):e13075. https:\/\/doi.org\/10.1111\/adb.13075","journal-title":"Addict Biol"},{"issue":"1","key":"835_CR123","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1124\/jpet.106.117382","volume":"321","author":"Z Xie","year":"2007","unstructured":"Xie Z, Miller GM (2007) Trace amine-associated receptor 1 is a modulator of the dopamine transporter. J Pharmacol Exp Ther 321(1):128\u2013136. https:\/\/doi.org\/10.1124\/jpet.106.117382","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"835_CR124","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10571-019-00774-5","volume":"40","author":"Z Xu","year":"2020","unstructured":"Xu Z, Li Q (2020) TAAR agonists. Cell Mol Neurobiol 40(2):257\u2013272. https:\/\/doi.org\/10.1007\/s10571-019-00774-5","journal-title":"Cell Mol Neurobiol"},{"issue":"7992","key":"835_CR125","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-023-06804-z","volume":"624","author":"Z Xu","year":"2023","unstructured":"Xu Z, Guo L, Yu J, Shen S, Wu C, Zhang W, Zhao C, Deng Y, Tian X, Feng Y, Hou H, Su L, Wang H, Guo S, Wang H, Wang K, Chen P, Zhao J, Zhang X et al (2023) Ligand recognition and G-protein coupling of trace amine receptor TAAR1. Nature 624(7992):672\u2013681. https:\/\/doi.org\/10.1038\/s41586-023-06804-z","journal-title":"Nature"},{"issue":"7","key":"835_CR126","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41386-023-01779-x","volume":"49","author":"SM Yang","year":"2024","unstructured":"Yang SM, Ghoshal A, Hubbard JM, Gackiere F, Teyssie R, Neale SA, Hopkins SC, Koblan KS, Bristow LJ, Dedic N (2024) TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner. Neuropsychopharmacology 49(7):1091\u20131103. https:\/\/doi.org\/10.1038\/s41386-023-01779-x","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"835_CR127","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.alcohol.2007.12.006","volume":"42","author":"N Yoneyama","year":"2008","unstructured":"Yoneyama N, Crabbe JC, Ford MM, Murillo A, Finn DA (2008) Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol 42(3):149\u2013160. https:\/\/doi.org\/10.1016\/j.alcohol.2007.12.006","journal-title":"Alcohol"},{"issue":"1","key":"835_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44601-4","volume":"15","author":"G Zilberg","year":"2024","unstructured":"Zilberg G, Parpounas AK, Warren AL, Yang S, Wacker D (2024) Molecular basis of human trace amine-associated receptor 1 activation. Nat Commun 15(1):108. https:\/\/doi.org\/10.1038\/s41467-023-44601-4","journal-title":"Nat Commun"},{"issue":"8","key":"835_CR129","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/sj.bjp.0706948","volume":"149","author":"R Zucchi","year":"2006","unstructured":"Zucchi R, Chiellini G, Scanlan TS, Grandy DK (2006) Trace amine-associated receptors and their ligands. Br J Pharmacol 149(8):967\u2013978. https:\/\/doi.org\/10.1038\/sj.bjp.0706948","journal-title":"Br J Pharmacol"}],"container-title":["Handbook of Experimental Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2026_835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:28:45Z","timestamp":1787567325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2026_835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":129,"URL":"https:\/\/doi.org\/10.1007\/164_2026_835","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"25 August 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}